TickerFacts.

Spyre Therapeutics, Inc. (SYRE): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$157.41M
Year ended 2024-12-31
2014-12-31: -$7.52M2015-12-31: -$11.19M2016-12-31: -$19.05M2017-12-31: -$25.23M2018-12-31: -$32.62M2019-12-31: -$67.18M2020-12-31: -$80.06M2021-12-31: -$54.29M2022-12-31: -$80.18M2023-12-31: -$99.91M2024-12-31: -$157.41M-$157.41M
2014-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$157.41Mn/m2026-02-19, From 2024-01-01
2023-12-31-$99.91Mn/m2026-02-19, From 2023-01-01
2022-12-31-$80.18Mn/m2025-02-27, From 2022-01-01
2021-12-31-$54.29Mn/m2024-11-18, From 2021-01-01
2020-12-31-$80.06Mn/m2023-03-02, From 2020-01-01
2019-12-31-$67.18Mn/m2022-03-08, From 2019-01-01
2018-12-31-$32.62Mn/m2021-03-18, From 2018-01-01
2017-12-31-$25.23Mn/m2020-02-24, From 2017-01-01
2016-12-31-$19.05Mn/m2019-03-07, From 2016-01-01
2015-12-31-$11.19Mn/m2018-03-13, From 2015-01-01
2014-12-31-$7.52Mn/a2017-03-23, From 2014-01-01